Detection of thymopoietin-responsive proteins in nude mouse spleen cells by two-dimensional polyacrylamide gel electrophoresis and image processing
- 1 January 1994
- journal article
- research article
- Published by Wiley in Electrophoresis
- Vol. 15 (1) , 984-987
- https://doi.org/10.1002/elps.11501501144
Abstract
Lymphoid cells isolated from the spleen of BALB/c nu/nu nude mice were treated with synthetic human thymopoietin, and newly synthesized proteins were labeled by [35S]methionine incorporation. In the control experiment, the same lot of spleen cells were incubated in the labeling medium without the addition of thymopoietin. Urea/detergent‐soluble proteins were extracted from the cells after 3 h incubation to be separated by two‐dimensional polyacrylamide gel electrophoresis. Spots of [35S]methionine‐labeled proteins were visualized by autoradiography and analyzed by image processing. The computer‐aided spot matching screened out three major thymopoietin‐responsive proteins, TRP‐1, −2 and −3. [35S]Methionine incorporation into TRP‐3, of which the isoelectric point and molecular mass were approximately pI5 and 10 kDa, respectively, was decreased by the thymopoietin treatment. In contrast with the down regulation, TRP‐1, which was slightly higher in pI and slightly larger in molecular mass, and TRP‐2, which was slightly higher in pI and almost the same in molecular mass as TRP‐3, were evidently induced by the treatment. However, TRPs could not be assigned to Thy‐1 antigen on the difference in molecular mass. The specific induction by the thymopoietin treatment suggested that TRP‐1 and −2 might be novel proteins related to the intracellular signal transduction.Keywords
This publication has 17 references indexed in Scilit:
- Immunomodulation and Sezary syndrome: experience with thymopentin (TP-5)British Journal of Dermatology, 1988
- Immunmodulierende Therapie der chronischen Polyarthritis mit Thymopentin: Eine multizentrische placebokontrollierte Studie an 119 PatientenDeutsche Medizinische Wochenschrift (1946), 1988
- Controlled Trial of Thymopentin in Hemodialysis Patients Who Fail to Respond to Hepatitis B VaccinationNephron, 1988
- THYMOPOIETIN PENTAPEPTIDE TREATMENT OF PRIMARY IMMUNODEFICIENCIESThe Lancet, 1983
- Synthesis of the octadecapeptide corresponding to positions 32 to 49 of the revised amino acid sequence of thymopoietin II and its effect on low E-rosette forming cells of an aged patient with chronic renal failure.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- Complete amino acid sequences of bovine thymopoietins I, II, and III: closely homologous polypeptidesBiochemistry, 1981
- The effect of thymopoietin II fragments and their analogs on E-rosette forming cells in the uremic state.CHEMICAL & PHARMACEUTICAL BULLETIN, 1980
- Immunological studies of aging. IV. The contribution of thymic involution to the immune deficiencies of aging mice and reversal with thymopoietin32-36.The Journal of Experimental Medicine, 1978
- Isolation of Bovine Thymin: a Polypeptide Hormone of the ThymusNature, 1974
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970